Skip to main content
Top
Published in: Journal of Cancer Education 1/2019

01-02-2019

Nurses’ Knowledge and Opinions on HPV Vaccination: a Cross-Sectional Study from Istanbul

Authors: Ayse Filiz Gokmen Karasu, Ilknur Adanir, Serdar Aydin, Gulsah Keskin Ilhan, Tugba Ofli

Published in: Journal of Cancer Education | Issue 1/2019

Login to get access

Abstract

Implementing a HPV vaccination program is currently under evaluation by the Turkish health ministry. For screening and vaccination programs to be successful, the cooperation of nurses is essential. We aimed to evaluate (1) basic knowledge of nurses and nursing interns regarding HPV infection and cervical cancer, (2) their attitudes towards smear testing and HPV vaccination, and (3) their viewpoint on vaccination of school age children. This cross-sectional study was undertaken at Bezmialem Vakif University. The survey was designed to assess knowledge about HPV infection, Pap smear testing, cervical cancer, HPV vaccine, attitudes towards HPV vaccination, and school-based vaccination programs. Validity content was determined by expert gynecologists, and a pilot study was performed on 10 nurses. A total of 550 questionnaires were handed out; 499 were completed. Our response rate was 90.7%. Fifty-nine participants answered all the knowledge questions correctly. The calculated knowledge score of the female participants was 6.99 ± 2.22, the male participants was 5.89 ± 2.92. Female participants were more knowledgeable (p < 0.0001). Out of the 353 female participants, 18.6% (n = 66) had undergone smear testing. There were 20 (5.6%) female and 6 (4%) male participants who were vaccinated against HPV. The leading answer for not having a HPV vaccine was “I’m not at risk for a HPV infection” (n = 106, 34.9%). There was a statistical relationship between “HPV knowledge score” and answering “Yes” to “Do you want your children/future children to be vaccinated? (p = 0.001) and “Do you think including the vaccine in the Turkish immunization program is necessary?” (p = 0.001). Nurses in our cohort seem to have satisfactory basic knowledge regarding HPV infection; however, their viewpoints on vaccination were not favorable. Strategies and intervention materials for HPV vaccination will be necessary if a national immunization program will be initiated.
Literature
1.
go back to reference Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRef Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRef
2.
go back to reference Lowy DR, Schiller JT (2012) Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 5:18–23CrossRef Lowy DR, Schiller JT (2012) Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 5:18–23CrossRef
3.
go back to reference Dalstein V, Riethmuller D, Prétet JL et al (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 3:396–403CrossRef Dalstein V, Riethmuller D, Prétet JL et al (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 3:396–403CrossRef
4.
go back to reference Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
5.
go back to reference de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615CrossRef de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615CrossRef
6.
go back to reference Cates W Jr (1999) Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 26:S2–S7CrossRef Cates W Jr (1999) Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 26:S2–S7CrossRef
7.
go back to reference Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19:531–538CrossRef Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19:531–538CrossRef
8.
go back to reference Meites E, Kempe A, Markowitz LE (2017) Use of a 2-dose schedule for human papillomavirus caccination—updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant 17:834–837CrossRef Meites E, Kempe A, Markowitz LE (2017) Use of a 2-dose schedule for human papillomavirus caccination—updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant 17:834–837CrossRef
9.
go back to reference Gültekin M, Akgül B (2017) HPV screening in Islamic countries. Lancet Infect Dis 4:368CrossRef Gültekin M, Akgül B (2017) HPV screening in Islamic countries. Lancet Infect Dis 4:368CrossRef
10.
go back to reference Genc RE, Sarican ES, Turgay AS et al (2013) Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pac J Cancer Prev 14:6775–6778CrossRef Genc RE, Sarican ES, Turgay AS et al (2013) Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pac J Cancer Prev 14:6775–6778CrossRef
11.
go back to reference Güvenç G, Akyüz A, Seven M (2012) Determination of the knowledge and attitudes of nursing students about human papilloma virus infection and its vaccines. Gulhane Med J 54:104–110CrossRef Güvenç G, Akyüz A, Seven M (2012) Determination of the knowledge and attitudes of nursing students about human papilloma virus infection and its vaccines. Gulhane Med J 54:104–110CrossRef
12.
go back to reference Bal-Yılmaz H, Koniak-Griffin D (2017) Knowledge, behaviors, and attitudes about human papilloma virus among nursing students in Izmir, Turkey. J Cancer Educ 1:1–7 Bal-Yılmaz H, Koniak-Griffin D (2017) Knowledge, behaviors, and attitudes about human papilloma virus among nursing students in Izmir, Turkey. J Cancer Educ 1:1–7
13.
go back to reference Koc Z, Cinarli T (2015) Cervical cancer, human papillomavirus, and vaccination: knowledge, awareness, and practices among Turkish hospital nurses. Nurs Res 64:452–465CrossRef Koc Z, Cinarli T (2015) Cervical cancer, human papillomavirus, and vaccination: knowledge, awareness, and practices among Turkish hospital nurses. Nurs Res 64:452–465CrossRef
14.
go back to reference Waller J, McCaffery K, Forrest S et al (2006) Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 13:208–213CrossRef Waller J, McCaffery K, Forrest S et al (2006) Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 13:208–213CrossRef
15.
go back to reference Goldie SJ, Kohli M, Grima D et al (2004) Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96:604–615CrossRef Goldie SJ, Kohli M, Grima D et al (2004) Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96:604–615CrossRef
16.
go back to reference Kane MA, Sherris J, Coursaget P et al (2006) HPV vaccine use in the developing world. Vaccine 24:S132–S139CrossRef Kane MA, Sherris J, Coursaget P et al (2006) HPV vaccine use in the developing world. Vaccine 24:S132–S139CrossRef
17.
go back to reference Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103:164–169CrossRef Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103:164–169CrossRef
18.
go back to reference Hswen Y, Gilkey MB, Rimer BK et al (2017) Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis 44:43–48CrossRef Hswen Y, Gilkey MB, Rimer BK et al (2017) Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis 44:43–48CrossRef
19.
go back to reference Jacob M, Bradley J, Barone MA (2005) Human papillomavirus vaccine: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs? Sex Transm Dis 32:635–640CrossRef Jacob M, Bradley J, Barone MA (2005) Human papillomavirus vaccine: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs? Sex Transm Dis 32:635–640CrossRef
20.
go back to reference Wong LP (2009) HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 27:1410–1415CrossRef Wong LP (2009) HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 27:1410–1415CrossRef
21.
go back to reference Brewer NT, Fazekas K (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45:107–114CrossRef Brewer NT, Fazekas K (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45:107–114CrossRef
23.
go back to reference Sam IC, Wong LP, Rampal S et al (2009) Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health 44:610–612CrossRef Sam IC, Wong LP, Rampal S et al (2009) Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health 44:610–612CrossRef
24.
go back to reference Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B (2014) Global polio eradication initiative: lessons learned and legacy. J Infect Dis 210(suppl 1):S540–S546CrossRef Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B (2014) Global polio eradication initiative: lessons learned and legacy. J Infect Dis 210(suppl 1):S540–S546CrossRef
25.
go back to reference Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL (2000) Measles eradication: is it in our future? Am J Public Health 90:1521–1525CrossRef Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL (2000) Measles eradication: is it in our future? Am J Public Health 90:1521–1525CrossRef
Metadata
Title
Nurses’ Knowledge and Opinions on HPV Vaccination: a Cross-Sectional Study from Istanbul
Authors
Ayse Filiz Gokmen Karasu
Ilknur Adanir
Serdar Aydin
Gulsah Keskin Ilhan
Tugba Ofli
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2019
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1272-x

Other articles of this Issue 1/2019

Journal of Cancer Education 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine